Alimera Sciences, Inc. stock is up 1.75% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 13 December’s closed higher than November.
Alimera Sciences, Inc. offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME) The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.